Clareon PanOptix Pro Toric
Asset
Replaces the natural lens to provide vision at far, intermediate, and near distances while correcting astigmatism.
- Stage
- Human trials
- Modality
- Device
- Target
- Not known
- 2
- Indications
- 1
- Trial
- 1
- Developer
Indications
2Aphakia
Human trials, Completed, NCT07161635, clinicaltrials.gov, 16 Oct 2026
Presbyopia
Human trials, Completed, NCT07161635, clinicaltrials.gov, 16 Oct 2026
In the full profile
- Owner and partners1
- Trials1
- Competitors10
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.